Triglycerides

Normal Triglycerides News

New Data Shows ACTEMRA Inhibits Progression Of Joint Destruction And Improves Physical Function Of Patients With ...Thursday, November 6, 2008 @ 7:07AMRoche announced that the innovative new therapy ACTEMRA (tocilizumab) can significantly inhibit structural damage to joints in patients with rheumatoid arthritis (RA) this is a critical measure of effectiveness of an RA treatment. ACTEMRA was also found to improve the patients' physical function after one year of therapy and to significantly increase the disease remission rate.

Cholesterol patients look to lifestyle, diet changes instead of drugsThursday, November 6, 2008 @ 2:45AMIn a single morning recently, Phoenix cardiologist Edward Diethrich saw four patients who wanted to talk about alternatives to cholesterol-lowering statin drugs.

*vwd/BUSINESS WIRE: 96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ^® ...Sunday, October 26, 2008 @ 12:37PMMITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.

New Phase III Study in Previously Untreated HIV Patients Showed Merck's ISENTRESS(R) (raltegravir) Reduced HIV Viral ...Sunday, October 26, 2008 @ 10:30AM WASHINGTON----In a new Phase III study that compared Merck & Co., Inc.'s HIV integrase inhibitor ISENTRESS® to efavirenz [one of the leading antiretrovirals prescribed for previously untreated HIV-infected patients ], ISENTRESS reduced HIV viral load to undetectable levels in 86 percent of patients compared to 82 percent of patients treated with efavirenz in previously untreated HIV patients at ...

Many Holes in Disclosure of Nominees’ HealthMonday, October 20, 2008 @ 1:59PMThe limited information provided by the candidates is a striking departure from recent campaigns in a year when their health carries extraordinary significance.